Om bidragsyterne

Dr. Michael Lim is Chair of the Department of Neurosurgery at Stanford with clinical interests in brain tumors as well as trigeminal neuralgia. He has garnered numerous teaching awards and has successfully led multiple phase I-III clinical trials for immunotherapy in glioblastoma. He is a member of multiple organizations and has served on the executive committee of the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. Dr. Michael Lim is Chair of the Department of Neurosurgery at Stanford with clinical interests in brain tumors as well as trigeminal neuralgia. He has garnered numerous teaching awards and has successfully led multiple phase I-III clinical trials for immunotherapy in glioblastoma. He is a member of multiple organizations and has served on the executive committee of the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. Dr. Michael Lim is Chair of the Department of Neurosurgery at Stanford with clinical interests in brain tumors as well as trigeminal neuralgia. He has garnered numerous teaching awards and has successfully led multiple phase I-III clinical trials for immunotherapy in glioblastoma. He is a member of multiple organizations and has served on the executive committee of the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.